REG - Nanoco Group PLC - Appointment of Non-Executive Director <Origin Href="QuoteRef">NANON.L</Origin>

NanocoAnnouncement

06/09/2014 14:29

For best results when printing this announcement, please click on the link
below:

http://pdf.reuters.com/Regnews/regnews.asp?i=43059c3bf0e37541&u=urn:newsml:reuters.com:20140709:nRSI7852La


RNS Number : 7852L
Nanoco Group PLC
09 July 2014 
 
 For immediate release  9 July 2014  
 
 
NANOCO GROUP PLC 
 
("Nanoco" or "the Company") 
 
Appointment of Non-Executive Director 
 
Nanoco Group plc (AIM: NANO), a world leader in the development and
manufacture of cadmium-free quantum dots and other nanomaterials, announces
the appointment of Robin Williams as an independent Non-Executive Director. 
 
Robinbrings to Nanoco a breadth of corporate experience, gained at quoted and
private businesses and in the City where he worked in investment banking
during his early career. He is currently a non-executive director at Xaar plc,
the Cambridge based inkjet print-head manufacturer. In addition, he chairs two
businesses owned by the Department of Health, NHS Professionals Ltd and NHS
Property Services Ltd.  He is also a non-executive at a quoted venture capital
trust and at a privately owned agricultural business. 
 
Robin qualified as an accountant in 1981 after graduating in engineering
science. He worked in corporate finance for ten years at investment banks
including Salomon Brothers and UBS before leaving the City in 1992 to co-found
the packaging business Britton Group plc. In 1998, he moved to Hepworth plc,
the building materials group, and since 2004 he has focused on non-executive
work in public, private and PE-backed businesses. 
 
It is intended that Robin will chair Nanoco's audit committee. 
 
Tony Clinch, Nanoco's Chairman, said: "We're delighted to welcome Robin
Williams to Nanoco's Board as a Non-Executive Director. Robin has a huge
breadth of corporate experience and we look forward to his contribution to the
Company." 
 
The following information is disclosed pursuant to Schedule Two paragraph (g)
of the AIM Rules for Companies. Robin George Walton Williams, age 57 years,
has been a director of the following companies during the five years preceding
the date of this announcement: 
 
Current directorships               Past directorships 
 
AH Worth & Co Ltd                    Constantine Group plc 
 
Baronsmead VCT 4 plc               Killby & Gayford Group Ltd 
 
NHS Professionals Ltd                Cagney plc 
 
NHS Property Services Ltd          Maxima Holdings plc 
 
Xaar plc                                     London Linen Supply Ltd 
 
26 Gledhow Gardens Ltd            DCI Inc. 
 
Bio Products Laboratory Holdings Ltd 
 
Bio Products Laboratory Ltd 
 
PRUK Ltd 
 
Further information to be disclosed: Killby & Gayford Group (covering Killby &
Gayford Consolidation, Killby & Gayford Holdings and Killby & Gayford Ltd.)
entered into administration in April 2012, approximately seven months
following Robin's resignation as non-executive chairman. Killby & Gayford
Group traded profitably throughout Robin's tenure. 
 
There is no further information to be disclosed pursuant to Rule 17 or
Schedule Two paragraph (g) of the AIM Rules for Companies. 
 
For further information please contact: 
 
 Nanoco                                      + 44 (0) 161 603 7900  
 Michael Edelman, Chief Executive Officer                           
 Colin White, Chief Financial Officer                               
 Canaccord Genuity - Nomad and Joint Broker  +44 (0) 20 7523 8000   
 Simon Bridges                                                      
 Cameron Duncan                                                     
 Liberum Capital - Joint Broker              +44 (0) 20 3100 2000   
 Simon Atkinson                                                     
 Richard Bootle                                                     
 Buchanan                                    + 44 (0) 20 7466 5000  
 Mark Court / Fiona Henson / Sophie Cowles                          
 
 
Mark Court / Fiona Henson / Sophie Cowles 
 
Notes for editors: 
 
About Nanoco Group plc 
 
Nanoco is a world leader in the development and production of cadmium-free
quantum dots and other nano-materials for use in multiple applications
including LCD displays, lighting, solar cells and bio-imaging. In the display
market, it has an exclusive manufacturing and marketing licensing agreement
with The Dow Chemical Company. 
 
Nanoco was founded in 2001 and is headquartered in Manchester, UK. It has
production facilities in Runcorn, UK, and a US subsidiary, Nanoco Inc, based
in Concord, MA. Nanoco also has business development offices in Japan, Korea
and Taiwan. Its technology is protected worldwide by a large and growing
patent estate. 
 
Nanoco began trading on the AIM market of the London Stock Exchange in May
2009 under the ticker symbol NANO. For further information please visit:
www.nanocogroup.com. 
 
This information is provided by RNS
The company news service from the London Stock Exchange